Safety Profile Comparison of 2 Smooth Tissue Expander Types: Artoura and CPX4.

Annals of plastic surgery 2024 Vol.93(2) p. 178-182

Almeida MN, Alper DP, Williams MCG, Shah R, Ihnat JMH, Hu K, Parikh N, Alperovich M

관련 도메인

Abstract

[INTRODUCTION] With the recent transition to smooth tissue expanders (TEs), functional differences between TE subtypes have not been fully elucidated. This study evaluated the differences in TE characteristics and complications between 2 commonly used Mentor smooth TE models, Artoura and CPX4.

[METHODS] A retrospective review of patients who received either smooth Mentor Artoura or CPX4 TE from 2012 to 2022 was conducted. Demographic data, perioperative information, pain scores, TE variables, cancer characteristics, and complications were collected. A multivariate analysis was used to evaluate the relationship between TE subtype and complications while controlling for demographic, TE characteristics, radiation, and chemotherapy exposure.

[RESULTS] During the study period, 62 smooth Artoura TEs and 79 smooth CPX4 TEs were used. Patients who received CPX4 smooth implants tended to be older (51.09 vs 46.18 years old, P = 0.02) and have a higher body mass index (28.66 vs 23.50 kg/m 2 , P < 0.001). There were no differences among patient comorbidities. CPX4 required on average a greater total fill volume (422.23 vs 348.07 mL, P = 0.01) and had a greater drain duration (16.91 vs 14.33 days, P = 0.05). There were no differences in TE plane placement between Artoura and CPX4. Additionally, there were no differences in complication rates, including infection, hematomas, seromas, wound breakdown, TE replacement, and capsular contracture. When controlling for body mass index, diabetes, TE plane placement, acellular dermal matrix use, radiation exposure, and chemotherapy, there was no association between TE subtype and any individual complication.

[DISCUSSION] Differences in total fill volume and drain duration were significantly different between Mentor Artoura and CPX4 implants, which may influence TE subtype selection. However, Artoura and CPX4 have excellent and equivalent safety profiles with similar complication rates, even when controlling for demographic and TE characteristics.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 smooth tissue expanders scispacy 1
해부 smooth scispacy 1
합병증 hematomas scispacy 1
합병증 seromas scispacy 1
합병증 wound scispacy 1
합병증 infection 감염 dict 1
합병증 capsular contracture 피막구축 dict 1
재료 acellular dermal matrix 무세포진피기질 dict 1
약물 [INTRODUCTION] scispacy 1
질환 pain C0030193
Pain
scispacy 1
질환 cancer C0006826
Malignant Neoplasms
scispacy 1
질환 hematomas C0018944
Hematoma
scispacy 1
질환 seromas C0262627
Seroma
scispacy 1
질환 diabetes C0011847
Diabetes
scispacy 1
질환 Smooth Tissue Expander Types scispacy 1
질환 TEs → tissue expanders scispacy 1
질환 smooth scispacy 1
기타 smooth TE scispacy 1
기타 patients scispacy 1
기타 TEs → tissue expanders scispacy 1
기타 patient scispacy 1
기타 capsular scispacy 1

MeSH Terms

Humans; Retrospective Studies; Middle Aged; Female; Male; Tissue Expansion Devices; Adult; Tissue Expansion; Postoperative Complications; Aged; Treatment Outcome

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문